Notice of 2017 Annual General Meeting
Admedus is pleased to announce the Annual General Meeting will be held at 11.00am (AEST) on 16 November 2017, at the Novotel Hotel in Brisbane, Australia.
October 13th 2017Find out more
Update on experts’ meeting (advisory board)
Recently, at the Admedus advisory board meeting run consecutively with the EACTS annual congress in Vienna, doctors validated the clinical benefits/medical utility and value to patients of our single piece aortic valve (vs. three piece leaflet from the competitors) in both the TAVR and SAVR settings. Our development work in this area continues as we […]Find out more
Investor webinar 5 September 2017
Admedus Limited (ASX: AHZ) held an investor webinar on 5 September, 2017 to discuss the results of the Company’s Preliminary Final Report (Appendix 4E) for the year ended 30 June 2017. Admedus CEO Wayne Paterson will provide a review of the Company’s year-end performance as well as operational and business highlights.
September 1st 2017Find out more
Admedus beats revenue forecasts for financial year 2017
Admedus has delivered a full year sales increase of 58% to $22.3 million for financial year 2017, compared to the previous financial year. Read more here.
August 31st 2017Find out more
Sponsorship supports kids with heart disease
Admedus Ltd is proud to announce a six-month $20k sponsorship of the HeartKids Education Program which provides vital resources for families of children living with congenital/childhood heart disease. In Australia, congenital/childhood heart disease is the leading cause of death for children under a year old and nearly three thousand babies are born with a heart […]
August 15th 2017Find out more
Admedus is a global healthcare company that develops, commercialises and distributes next generation medical technologies and devices. Our mission is to provide patients around the world with a better quality of life through access to our leading medical solutions and products.Learn More